Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Soleno Therapeutics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 50.7M | 48.8M | −1.85M (−3.7%) |
| Value | $11.2M | $8.80M | −$2.44M (−21.7%) |
New holders (7)
Institutions that held Soleno Therapeutics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 67,569 | $12.0K | 0.00% |
| UBS Group AG | 54,695 | $10.0K | 0.00% |
| Millennium Management LLC | 46,318 | $9.00K | 0.00% |
| HRT Financial LP | 47,726 | $8.00K | 0.00% |
| Onyx Bridge Wealth Group LLC | 20,000 | $4.00K | 0.00% |
| Two Sigma Securities, LLC | 12,724 | $2.00K | 0.00% |
| Citigroup Inc | 526 | $0 | 0.00% |
Sold out (8)
Institutions that held Soleno Therapeutics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Empery Asset Management, LP | 1,401,400 | $313.0K |
| Boothbay Fund Management, LLC | 252,154 | $56.0K |
| Ikarian Capital, LLC | 128,454 | $29.0K |
| Victory Capital Management Inc | 13,387 | $3.00K |
| Jane Street Group, LLC | 13,998 | $3.00K |
| Morgan Stanley | 43 | $0 |
| Simplex Trading, LLC | 156 | $0 |
| Bray Capital Advisors | 2,000 | $0 |